• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT CA 19-9XR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT CA 19-9XR Back to Search Results
Catalog Number 02K91-38
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/12/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, architect ca 19-9 (list 02k91-38), that has a similar product in the us (list 02k91-29 and 02k91-33), which is manufactured in abbott park, il usa.
 
Event Description
The customer observed a falsely elevated undiluted architect ca19-9xr result of >1200 u/ml for sample id (b)(4).After automatic 1:10 dilution the results were 275.3, 233.2, and 259.71.After manual dilution at 1:2, 1:4, 1:8, 1:16 were, respectively: 867.2, 431.6, 305.6, 252.8.The customer suspects an interference in the sample.No impact to patient management reported.
 
Manufacturer Narrative
Udi # = (b)(4); lot # = 88015m800.This report is being filed on an international product, architect ca 19-9 (list 02k91-38), that has a similar product in the us (list 02k91-29 and 02k91-33), which is manufactured in (b)(4).The customers instrument logs were reviewed and did not identify conclusive information to indicate an instrument or sample integrity issue.Review of complaint activity determined that there was normal complaint activity for the likely cause lot 88015m800.Tracking and trending report review for the architect ca 19-9xr assay determined that there were no related adverse or non-statistical trends.Using worldwide field data the performance of reagent lot 88015m800 was evaluated.The median result is within the established control limits.Labeling was reviewed and sufficiently addresses the customer's issue.No systemic issue or deficiency of the architect ca19-9 xr assay was identified.
 
Manufacturer Narrative
An error was identified on 16jan2019.This report was filed against the incorrect manufacturing site.Manufacturer report 3002809144-2019-00021 has been submitted to correct this, and all follow up information will be provided in that report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT CA 19-9XR
Type of Device
CA 19-9
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key8110493
MDR Text Key129352152
Report Number1415939-2018-00161
Device Sequence Number1
Product Code NIG
Combination Product (y/n)N
PMA/PMN Number
K052000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 01/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/12/2019
Device Catalogue Number02K91-38
Device Lot Number88015M800
Was Device Available for Evaluation? Yes
Date Manufacturer Received01/16/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-02; ARCHITECT I2000SR, LIST 03M74-02; SERIAL (B)(4) ; SERIAL (B)(4)
-
-